Exhalation delivery system with fluticasone improves quality of life and health status: pooled analysis of phase 3 trials NAVIGATE I and II

ConclusionIn this pooled analysis of 2 large pivotal EDS ‐FLU trials, health domain and health utilities improvements were significantly greater with EDS‐FLU than EDS‐PBO and were comparable to population norms.

Source: International Forum of Allergy and Rhinology - May 21, 2020 Category: Allergy & Immunology Authors: Zachary M. Soler, Sam Colman, Fulton F. Velez, Rodney J. Schlosser Tags: ORIGINAL ARTICLE Source Type: research